MENU
Showcases Stock ranks Forex

Novocure Ltd Ord Sh (NVCR)
15.63  0.99 (6.76%) 03-28 16:00
Open: 14.55 Pre. Close: 14.64
High: 16.05 Low: 14.38
Volume: 2,403,276 Market Cap: 1,674(M)
Stock Technical Analysis
Overall:     
Target: Six months: 21.07
One year: 24.61
Support: Support1: 14.86
Support2: 12.90
Resistance: Resistance1: 18.04
Resistance2: 21.07
Pivot: 14.39
Moving Averages: MA(5): 13.95
MA(20): 14.94
MA(100): 13.97
MA(250): 29.87
MACD: MACD(12,26): -0.32
Signal(12,26,9): -0.32
%K %D: %K(14,3): 30.09
%D(3): 16.11
RSI: RSI(14): 56.91
52-Week: High: 83.6
Low: 10.87
Change(%): -73.2
Average Vol(K): 3-Month: 1405
10-Days: 2318
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 16.077 - 16.154 16.154 - 16.224
Low: 14.205 - 14.288 14.288 - 14.363
Close: 15.485 - 15.63 15.63 - 15.761
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.

[ NVCR ] has closed below upper band by 20.4%. Bollinger Bands are 47.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.
Company profile
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Stock chart
Stock News
Thu, 18 Jan 2024
Healthcare Stocks on the Move Thursday: MRAI, JSPR, NVCR, ELVN, RNAZ, PBLA, PRQR, CANO - InvestorsObserver

Mon, 12 Jun 2023
3 Small-Cap Drug Stocks to Watch as Their Clinical Trials End Soon - InvestorPlace

Fri, 29 Mar 2024


Fri, 29 Mar 2024


Fri, 29 Mar 2024


Fri, 29 Mar 2024


Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  NASDAQ Global Select
Sector:  Healthcare
Industry:  Medical - Instruments & Supplies
Shares Out. (M) 107.09
Shares Float (M) 95.92
% Held by Insiders 1.67
% Held by Institutions 85.97
Shares Short (K) 5640
Shares Short Prior Month (K) 5770
Stock Financials
EPS -1.950
Book Value (p.s.) 3.380
Profit Margin -40.65
Operating Margin -33.64
Return on Assets (ttm) -12.1
Return on Equity (ttm) -51.5
Qtrly Rev. Growth 4.2
Gross Profit (p.s.)
Sales Per Share 4.756
EBITDA (p.s.) -2.021
Qtrly Earnings Growth
Operating Cash Flow (M) -73.34
Levered Free Cash Flow (M) -10.20
Stock Valuation
PE Ratio -8.02
PEG Ratio -0.13
Price to Book value 4.62
Price to Sales 3.29
Price to Cash Flow -22.82
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android